L-(+)-Tartaric acid

ALDRICH/W304409 - ≥99.7%, FCC, FG

Synonym: (2R,3R)-(+)-Tartaric acid; L-Threaric acid

CAS Number: 87-69-4
Empirical Formula (Hill Notation): C₄H₆O₆
Molecular Weight: 150.09
EC Number: 201-766-0
MDL Number: MFCD00064207
Linear Formula: HO₂CCH(OH)CH(OH)CO₂H
Product Type: Chemical

Catalog Number	PKG Qty.	Price


45-W304409-1KG	1 kg	$96.20 1/EAAdd To Favorites	Add To Favorites
45-W304409-10KG	10 kg	$0.00 1/EA CALL FOR PRICEAdd To Favorites	Add To Favorites
45-W304409-SAMPLE		$54.60 1/EAAdd To Favorites	Add To Favorites

agency	meets purity specifications of JECFA
application(s)	flavors and fragrances
assay	≥99.7%
autoignition temp.	797 °F
biological source	synthetic
cation traces	As: ≤3 ppm
	Cd: ≤1 ppm
	heavy metals (as Pb): ≤2 ppm
	Hg: ≤1 ppm
documentation	see Safety & Documentation for available documents
food allergen	no known allergens
form	crystalline powder
grade	FG
	Halal
InChI	1S/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)/t1-,2-/m1/s1
InChI key	FEWJPZIEWOKRBE-JCYAYHJZSA-N
mp	170-172 °C (lit.)
optical activity	[α]20/D +12.5°, c = 20 in H₂O
organoleptic	odorless
Quality Level	400
reg. compliance	EU Regulation 1334/2008 & 178/2002
	FCC
	FDA 21 CFR 163.110
	FDA 21 CFR 163.111
	FDA 21 CFR 163.112
	FDA 21 CFR 184.1099
SMILES string	O[C@H]([C@@H](O)C(O)=O)C(O)=O
solubility	water: soluble 150 g/L at 25 °C
vapor density	5.18 (vs air)

Application:	Terahertz-spectroscopy for non-destructive determination of crystallinity of L-tartaric acid in smartFilms and tablets made from paper.: This study leverages terahertz spectroscopy to assess the crystallinity of L-(+)-tartaric acid in innovative pharmaceutical applications, enhancing non-destructive testing methods for quality control (Ornik et al., 2020 May). Link to the article . Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations.: Research shows the use of L-(+)-tartaric acid in cocrystal formulations with itraconazole to improve its pulmonary absorption, demonstrating a significant advancement in drug delivery technologies (Karashima et al., 2017 Jun). Link to the article . Physicochemical Evaluation and Developability Assessment of Co-amorphouses of Low Soluble Drugs and Comparison to the Co-crystals.: This article discusses the role of L-(+)-tartaric acid in enhancing the solubility and bioavailability of pharmaceuticals through co-amorphous systems, offering a critical insight into drug formulation strategies (Yamamoto et al., 2016 Dec). Link to the article . Functionalized polycarbonate derived from tartaric acid: enzymatic ring-opening polymerization of a seven-membered cyclic carbonate.: This research explores the synthesis of biodegradable polymers from L-(+)-tartaric acid, emphasizing its utility in developing environmentally friendly materials (Wu et al., 2008 Oct). Link to the article .
General description:	L-(+)-Tartaric acid is an organic acid commonly used as an acidulant, flavor enhancer, firming agent and humectant.
Packaging:	1 kg in poly bottle
Packaging:	5, 10 kg in poly drum

Symbol	GHS05
Signal word	Danger
Hazard statements	H318
Precautionary statements	P280 - P305 + P351 + P338
Hazard Codes	Xi
Risk Statements	41
Safety Statements	26-36/37/39
RIDADR	NONH for all modes of transport
WGK Germany	WGK 1
Flash Point(F)	302.0 °F - closed cup
Flash Point(C)	150 °C - closed cup

Purity	≥99.7%
mp	170-172 °C (lit.)
FEMA Number	3044
UNSPSC	12164502